Gayathri Swaminath

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

Total Citations

H-Index

About

Gayathri Swaminath is a biomedical engineer whose research focuses on developing scalable, high-throughput tools for cardiac electrophysiology. Her most notable contribution is the creation of a fully-automated, low-cost cardiac monolayer optical mapping robot (2023), which addresses a critical bottleneck in drug development by enabling simultaneous measurement of key electrophysiological parameters like action potentials and intracellular calcium transients. This work, already garnering 3 citations, promises to accelerate the elucidation of cardiac disease mechanisms and improve the efficiency of preclinical drug screening. Swaminath’s innovation lies in democratizing advanced optical mapping technology—traditionally expensive and labor-intensive—making it accessible for broader research applications. Her efforts are particularly impactful for studying arrhythmias and cardiotoxicity, where high-throughput, reproducible data are essential. By merging robotics with electrophysiology, Swaminath is paving the way for more rapid and cost-effective cardiac research, positioning her as an emerging leader in the field of automated biomedical instrumentation.